Related references
Note: Only part of the references are listed.GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
Liselotte van Bloemendaal et al.
DIABETES (2014)
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
M. E. J. Lean et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect
Stephanie Sisley et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
L. van Bloemendaal et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward
India A. Reddy et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
Michaela Diamant et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
A link between FTO, ghrelin, and impaired brain food-cue responsivity
Efthimia Karra et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Obesity and addiction: neurobiological overlaps
N. D. Volkow et al.
OBESITY REVIEWS (2013)
The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
Emil Egecioglu et al.
PLOS ONE (2013)
The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
Suzanne L. Dickson et al.
JOURNAL OF NEUROSCIENCE (2012)
Food and drug cues activate similar brain regions: A meta-analysis of functional MRI studies
D. W. Tang et al.
PHYSIOLOGY & BEHAVIOR (2012)
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Tina Vilsboll et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
Mark Fineman et al.
CLINICAL PHARMACOKINETICS (2011)
Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
Michael A. Nauck et al.
DIABETES (2011)
Peptide hormones regulating appetite - focus on neuroimaging studies in humans
Haiko Schloegl et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4
Scott E. Kanoski et al.
ENDOCRINOLOGY (2011)
Attentional Bias to Food Images Associated With Elevated Weight and Future Weight Gain: An fMRI Study
Sonja Yokum et al.
OBESITY (2011)
The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
Kent C. Berridge et al.
BRAIN RESEARCH (2010)
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
Niels Vrang et al.
PROGRESS IN NEUROBIOLOGY (2010)
Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors
Todd A. Hare et al.
JOURNAL OF NEUROSCIENCE (2008)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele
E. Stice et al.
SCIENCE (2008)
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans
Susanne Lerche et al.
DIABETES (2008)
Relation of Reward From Food Intake and Anticipated Food Intake to Obesity: A Functional Magnetic Resonance Imaging Study
Eric Stice et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2008)
PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans
Rachel L. Batterham et al.
NATURE (2007)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
LL Baggio et al.
DIABETES (2004)
Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length
KL Feltrin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Images of desire: food-craving activation during fMRI
ML Pelchat et al.
NEUROIMAGE (2004)
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration
WA Banks et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Dissociation of neural representation of intensity and affective valuation in human gustation
DM Small et al.
NEURON (2003)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Brain dopamine is associated with eating behaviors in humans
ND Volkow et al.
INTERNATIONAL JOURNAL OF EATING DISORDERS (2003)
Changes in brain activity related to eating chocolate - From pleasure to aversion
DM Small et al.
BRAIN (2001)
The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings
RJ Stubbs et al.
BRITISH JOURNAL OF NUTRITION (2000)
Cortical activation induced by intraoral stimulation with water in humans
DH Zald et al.
CHEMICAL SENSES (2000)
Share Paper
